| |
|
|
|
Seaport World Trade Center, Boston, MA, USA
May 5-7, 2014
Advances in molecular biology and biotechnology have allowed for the large-scale production of effective and potent biotherapeutic drugs. Major research issues in protein/peptide delivery include the stabilization of proteins in delivery devices and the design of appropriate target-specific carriers. CHI's Inaugural Biologics Formulation and Delivery Summit will provide a forum for focused discussions on current challenges and opportunities in delivery of biotherapeutics. This multi-track summit will discuss various formulation and device-based approaches for designing physiologically relevant, patient friendly, targeted biologics products. - Formulation Strategies for Improved Delivery of Biologics (May 5-6)
Overcoming Challenges in Injectable Drug Delivery via Breakthrough Delivery and Device Strategies
- New Technologies for Biologics Delivery and Targeting (May 6-7)
Driving Innovation Through New Targets, Effective Tools, Next-Gen and Alternate Delivery Technologies
|
|
|
|
|
|
|
|
Organized by:
|
|
Cambridge Healthtech Institute |
|
|
Invited Speakers:
|
|
- Julia Rashba-Step, Ph.D., Senior Director, Novel Delivery Technologies, Pfizer, Inc.
- Sujit K. Basu, Ph.D., Senior Director, Drug Product Development, Shire Human Genetic Therapies
- Carsten Olbrich, Ph.D., Senior Scientist, Formulation Development, Bayer Pharma AG
- Weiguo Dai, Ph.D., Scientific Director, Fellow, Drug Product Development, Johnson & Johnson
- Sarangapani Prasad, Ph.D., Post Doctoral Research Fellow, MedImmune, Inc.
- Tarun Mandal, Ph.D., McCaffrey/Norwood Endowed Professor of Pharmacy & Director, Center for Nanomedicine & Drug Delivery, College of Pharmacy, Xavier University of Louisiana
- Russell G. Burge, Ph.D., Application Scientist, Freeslate, Inc.
- Robert K. Prud’homme, Ph.D., Professor and Director Program in Engineering Biology, Department of Chemical & Biological Engineering, Princeton University
- Kevin Constable, Director, Technology Development, Global Pharmaceutical Solutions, Terumo Medical Corporation
- Ian W. Hunter, Ph.D., Hatsopoulos Professor, Department of Mechanical Engineering, Mechanical Engineering, MIT
- William J. Lambert, Ph.D., Fellow, Drug Delivery and Device Development, MedImmune, Inc.
- Cindy Wu, Ph.D., Principal Scientist, Pharmaceutical Sciences, Allergan, Inc.
- Ashim K. Mitra, Ph.D., University of Missouri Curators’ Professor of Pharmacy, Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City
- Amar Sawhney, Ph.D., President & CEO, Ocular Therapeutix, Inc., President, Ocular Therapeutix, Inc.
- Robert Kelley, Ph.D., Senior Scientist, Drug Delivery, Genentech, Inc.
- Omid Farokhzad, M.D., Associate Professor, Laboratory of Nanomedicine and Biomaterials, Department of Anesthesiology, Brigham and Women’s Hospital and
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
---
|
|
|
|
|
|
|
|
Registration:
|
|
Register now
|
|
|
E-mail:
|
|
kwaterman@healthtech.com
|
|
|
|
|
|
|
|
|